| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2797 | |||||||||||||||||||||||
| Submitter : | Miss. Kelly Schexnayder | Date & Time: | 12/08/2006 09:12:14 | |||||||||||||||||||||
| Organization : | Miss. Kelly Schexnayder | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| Please do not allow the use of fetal stem lines for development of new vaccines. Because I hold that these fetuses are human, I will not be able to use any vaccines that developed. Rather, encourage the use of ethical alternatives for the development of viral vaccines so that none of America will be denied these vaccines. | ||||||||||||||||||||||||